* Q2 adjusted earnings C$0.23/share vs C$0.19 year-earlier
* Generics unit Pro Doc
* Same-store sales up 2.6 percent
(Recasts first sentence with adjusted earnings, results fromgenerics unit; adds same-store sales.)
Oct 10 (Reuters) - Canadian pharmacy chain Jean Coutu GroupInc reported a rise in adjusted quarterly earnings onWednesday, as its generic drug manufacturing subsidiary Pro Docposted a double-digit gain in sales and operating income.
Prescription sales growth at Longueuil, Quebec-based JeanCoutu and rivals such as Shoppers Drug Mart Corp hasbeen hurt in recent years by a provincial crackdown on genericdrug prices and reimbursement rules. But Jean Coutu has said ProDoc should help boost margins over the long term.
Pro Doc's sales rose 14.0 percent to C$38.3 million ($39.2million) for the second quarter ended Sept. 1, and itscontribution to operating income before amortization rose 25.2percent to C$15.4 million.
Excluding a gain related to Jean Coutu's stake in U.S.drugstore chain Rite Aid Corp and other items, earningsrose to C$50.0 million, or 23 Canadian cents a share, comparedwith C$44.6 million, or 19 Canadian cents, a year earlier.
On an unadjusted basis, net profit fell to C$51.2 million($52.3 million), or 23 Canadian cents a share, from C$66.4million, or 29 Canadian cents.
Revenue rose to C$658.7 million from C$635.2 million. Salesat established stores, a key measure for retailers, rose 2.6percent.
($1 = $0.98 Canadian)
(Reporting by Allison Martell; Editing by Leslie Adler)
Keywords: JEANCOUTU RESULTS/